The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Mutational analysis of circulating tumor cells in breast cancer patients by targeted clonal sequencing.
Xunhai Xu
No relevant relationships to disclose
Yufeng Shen
No relevant relationships to disclose
William Dewitt
No relevant relationships to disclose
Deep Pandya
No relevant relationships to disclose
Farideh Z. Bischoff
Employment or Leadership Position - Biocept
Katherine D. Crew
No relevant relationships to disclose
Dawn L. Hershman
No relevant relationships to disclose
Matthew A. Maurer
No relevant relationships to disclose
Ramon Parsons
No relevant relationships to disclose
Kevin Kalinsky
No relevant relationships to disclose